| | Black Hall | Blue Hall 1 | Blue Hall 2 | eURO Auditorium | Gold Hall | Green Hall 1 | Green Hall 2 | Green Hall 3 | Orange Hall 1 | Orange Hall 2 | Orange Hall 3 | Purple Hall 1 | Purple Hall 2 | Red Hall 1 | Red Hall 2 | Silver Hall | White Hall 2 | Yellow Hall 2-3 |
| 08:00 | 08:00 - 19:00 VIP Suite
VIP Suite
08:00 - 19:00 Latin Suite
Latin Suite
08:00 - 19:00
Asian Suite
|
| | | 07:45 - 11:00 Plenary Session 1
Uro-oncology: Focus on lymph nodes
|
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| 09:00 | | | | | 09:00 - 12:00 ESU Course 1
Paediatric urology for the adult urologist: A practical update

|
09:00 - 12:00 ESU Course 2
Prostate cancer ? screening, diagnosis and staging

|
09:00 - 12:00 ESU Course 3
Update on stone disease

|
09:00 - 12:00 ESU Course 4
Retropubic radical prostatectomy ? tips, tricks and pitfalls

|
09:00 - 12:00 ESU Course 5
Treatment of advanced and metastatic renal cancer

|
09:00 - 12:00 ESU Course 6
Evaluation and management of female pelvic floor disorders

|
| | | | | | |
| 09:15 - 10:45 Oral Session 6
Sexual dysfunction
|
09:15 - 10:45 Poster Session 21
Prostatitis and chronic pelvic pain
|
09:15 - 10:45 Poster Session 22
LUTS, the prostate and sexual function
|
| | | 09:15 - 10:45 Poster Session 18
Stress incontinence - tapes, new concepts and more
|
09:15 - 10:45 Poster Session 19
Urolithiasis: Diagnosis and medical therapy
|
| | 09:15 - 10:45 Poster Session 20
Prostate cancer: Prognostic factors and predictors of outcome
|
| 10:00 | | | | | 10:00 - 12:30
ESU/ESUT Hands-on training laparoscopy course 1

|
| | | | |
| 11:00 | 11:00 - 12:00 Sub-plenary Session 3
Joint session of the European Association of Urology (EAU) and the European Society for Medical Oncology (ESMO): Contemporary debates on prostate and renal cancer
|
| | 11:00 - 12:00 Sub-plenary Session 1
Molecular biomarkers for prostate cancer: What's new
|
11:00 - 12:00 Sub-plenary Session 2
The risk of prostate cancer and kidney transplantation
|
| | 11:00 - 12:00 Sub-plenary Session 4
Male urinary incontinence
|
| | |
| | | | | | | |
| 12:00 | | | | | | | | | | | | | | | | 12:00 - 14:00 Workshop
Utilising new technology when performing ureteroscopy and PCNL

Sponsored by BOSTON SCIENTIFIC
|
|
| 12:15 - 13:45 Poster Session 23
Learning curve and outcome in radical prostatectomy
|
12:15 - 13:45 Poster Session 27
Bladder dysfunction: What is new about receptors and drugs
|
12:15 - 13:45 Poster Session 28
Sexual function: Ejaculation and female function
|
12:15 - 13:45 Video Session 3
BPH surgery: A new battlefield!
|
12:15 - 13:45 Oral Session 7
Renal tumours: Diagnosis and imaging
|
12:15 - 15:15 ESU Course 7
Chronic pelvic pain syndromes (CPPS) with special focus on chronic prostatitis (CP) and painful bladder syndrome/interstitial cystitis (PBS/IC)

|
12:15 - 15:15 ESU Course 8
Advanced course on urethral stricture surgery

|
12:15 - 15:15 ESU Course 9
Diagnosis and management of non-muscle invasive bladder cancer (NMIBC)

|
12:15 - 15:15 ESU Course 10
Office management of male sexual dysfunction

|
12:15 - 15:15 ESU Course 11
Lower urinary tract dysfunction and urodynamics

|
12:15 - 15:15 ESU Course 12
Metastatic prostate cancer

|
12:15 - 13:45 Poster Session 29
Open surgery and PCNL for stones
|
| 12:15 - 13:45 Poster Session 24
BPH: Medical therapy II
|
12:15 - 13:45 Poster Session 25
Prostate cancer tumour biology
|
| 12:15 - 13:45 Poster Session 26
Treatment of superficial bladder tumours I
|
| 13:00 | | |
| | |
| 14:00 | 14:00 - 15:30 Poster Session 30
Prostate cancer screening and new risk factors
|
14:00 - 15:30 Poster Session 34
Management of neurogenic bladder dysfunction
|
14:00 - 15:30 Poster Session 35
Erectile dysfunction: From bench to clinic
|
14:00 - 15:30 Video Session 4
Male continence and reconstructive surgery
|
14:00 - 15:30 Oral Session 8
Renal tumours: Surgical treatment
|
14:00 - 15:30 Poster Session 36
Adrenal surgery and kidney transplantation
|
| 14:00 - 15:30 Poster Session 31
BPH: Surgical treatment
|
14:00 - 15:30 Poster Session 32
Novel aspects in hormonal treatment, biomarkers and prognostic factors
|
| 14:00 - 16:30
ESU/ESUT Hands-on training laparoscopy course 2

|
14:00 - 15:30 Poster Session 33
Urothelial tumours: Basic research I
|
| | |
| 15:00 | | |
| | | | | | 15:30 - 17:30 ESU Course 13
Urological management of renal failure and renal transplantation ? treatment of urological complications

|
15:30 - 17:30 ESU Course 14
Laparoscopy for beginners

|
15:30 - 17:30 ESU Course 15
The molecular basis of urological disease: science in practice

|
15:30 - 17:30 ESU Course 16
How to write a paper for publication

|
15:30 - 17:30 ESU Course 17
Management and outcome in invasive and locally advanced bladder cancer

|
15:30 - 17:30 ESU Course 18
Minimally invasive treatment for localised prostate cancer

|
| | | | | |
| 16:00 | 15:45 - 17:15 Poster Session 37
High-grade PIN, ASAP and pathological markers
|
15:45 - 17:15 Poster Session 41
OAB: From symptoms to management
|
15:45 - 17:15 Poster Session 42
Potency, continence and quality of life after radical prostatectomy
|
15:45 - 17:15 Video Session 5
Endoscopic surgery of the upper urinary tract
|
15:45 - 17:15 Oral Session 9
Treatment of advanced stage bladder and upper urinary tract cancer
|
15:45 - 17:15 Oral Session 10
Reconstructive bladder and upper urinary tract surgery
|
| 15:45 - 17:15 Poster Session 38
Paediatric urology: Penile and testis disorders, trauma, obstruction and voiding dysfunction
|
15:45 - 17:15 Poster Session 39
Chemotherapy and new concepts in hormone refractory prostate cancer
|
16:00 - 17:00 Workshop
Advances in pelvic floor reconstruction and stress urinary incontinence

Sponsored by BOSTON SCIENTIFIC
|
15:45 - 17:15 Poster Session 40
Prostate cancer: Active surveillance and prognostic factors
|
| | |
| 17:00 | | | |
| 17:30 - 19:00 Symposium
Warning! An urgent symposium

Sponsored by ASTELLAS
|
17:30 - 19:00 Symposium
Testosterone deficiency syndrome - From epidemiology to future directions

Sponsored by PIERRE FABRE MEDICAMENT
|
17:30 - 19:00 Symposium
Case study review of moderate and high-risk non-muscle invasive bladder cancer

Sponsored by SANOFI PASTEUR
|
17:30 - 19:00 Symposium
Directions in chemotherapy for advanced prostate cancer: Your team, your patient, your choice

Sponsored by SANOFI-AVENTIS
|
17:30 - 19:00 Symposium
New perspectives on the management of men with LUTS and BPH: Evaluating the impact of the CombAT study

Sponsored by GLAXOSMITHKLINE
|
| | | | | | | 17:30 - 19:00 Workshop
Cryosurgery of prostate and kidney cancers: Present and future

Sponsored by ENDOCARE
|
17:30 - 19:00 Symposium
Improving clinical outcomes in genitourinary malignancies: Focus on prostate cancer and kidney cancer

Sponsored by NOVARTIS ONCOLOGY
|
17:30 - 19:00 Symposium
Continued progress in the treatment of advanced renal cell carcinoma: An update on the role of sunitinib

Sponsored by PFIZER INC
|
| | 17:30 - 19:00 Symposium
Exploring issues and unmet needs in hormone-resistant prostate cancer

Sponsored by ASTRAZENECA
|
| 18:00 | | | | | | | | | |
| | | | | | | | | |